Cancer immunotherapy is increasingly being evaluated as an approach to cancer treatment by harnessing the immune system to attack cancer cells. Both the adaptive and innate arms of the immune system play a pivotal role in a host’s defense against tumors. CD8+ cytotoxic T lymphocytes (CTLs), which constitute a major component of the adaptive immune […]
The post Multifunctional Potency Assays for Cancer Immunotherapy appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Multifunctional Potency Assays for Cancer Immunotherapy